Figure S3 from Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody

التفاصيل البيبلوغرافية
العنوان: Figure S3 from Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody
المؤلفون: Shahram Salek-Ardakani, John C. Lin, Arvind Rajpal, Eugenia Kraynov, Jeffrey Chou, Jerry D. Clark, Allison Xu, Christopher P. Dillon, Natalija Budimir, Brent Kern, Bart Jessen, Cris Kamperschroer, Sherman M. Chin, Christopher R. Kimberlin, Joyce Chou, HoangKim Nguyen, Yasmina Abdiche, Sawsan Youssef, Amir A. Al-Khami
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Supplementary Figure 3 shows the analysis of the primary structure of sasanlimab by LC-MS peptide mapping.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fe32b1646ca3f9cae8a0e42986063e1
https://doi.org/10.1158/1535-7163.22521589.v1
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....2fe32b1646ca3f9cae8a0e42986063e1
قاعدة البيانات: OpenAIRE